Cogent Biosciences COGT
$26.72 −$1.03 (-3.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.20 +1.82%
Open$27.26
Prev close$27.74
Day range$26.62 – $27.83
Volume2.13M
Market cap$4.65B
P/E (TTM)–
Dividend yield–
COGT Stock News
Headlines matching Cogent Biosciences or the COGT ticker, most recent first.
- J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating, Announces Target Price $62
- Wedbush Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55
- H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55
- LifeSci Capital Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55
- Piper Sandler Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $55 Positive
- Guggenheim Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $52 Positive
- Needham Maintains Cogent Biosciences(COGT.US) With Hold Rating
- Stifel Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $45
- UBS Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $60
- Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR)
- J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating
- Piper Sandler Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $52
- A Quick Look at Today's Ratings for Cogent Biosciences(COGT.US), With a Forecast Between $45 to $55
- Guggenheim Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $45
- H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $52
No comments yet — be the first to weigh in on COGT.
Sign in to join the discussion.